Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan-Feb;15(1):40-48.
doi: 10.1097/ADM.0000000000000672.

Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study

Ana L Hincapie  1 , Michael Hegener, Pamela C Heaton, Gabrielle Fish, Kathryn Fetters, Gregory T Sneed, Kathleen Koechlin, Jolene DeFiore-Hyrmer, Amy Holthusen, Neil J MacKinnon
Affiliations

Challenges and Facilitators of Implementing a Physician-approved Naloxone Protocol: A Mixed-methods Study

Ana L Hincapie et al. J Addict Med. 2021 Jan-Feb.

Abstract

Objectives: In 2015, the State of Ohio passed legislation to allow pharmacists to dispense naloxone under a physician-approved protocol. The legislation allows all individuals authorized under a physician-approved protocol to personally furnish naloxone without requiring clients to be seen by a licensed prescriber, thus expanding the capacity of Ohio's community distribution programs. We aimed to evaluate the implementation of legislation allowing for a physician-approved protocol in pharmacies and other naloxone distribution sites in Ohio, and to compare barriers and facilitators of implementing the law changes among sites that implemented a physician-approved protocol versus sites that did not.

Methods: The study used a convergent parallel mixed-method design. Random samples from all pharmacies registered with the State of Ohio Board of Pharmacy and community naloxone distribution sites were selected. Quantitative data were collected via survey (n = 168) and qualitative data were collected via semi-structured interviews (n = 17).

Results: Most survey respondents agreed that the policy has expanded access to naloxone at their site for individuals who want or need the medication. Both pharmacies and other naloxone distribution sites identified that leadership and organizational support facilitated protocol implementation and cost, stigma, and lack of naloxone demand challenged protocol implementation.

Conclusions: The study identified barriers and facilitators to the implementation of a physician-approved protocol within Ohio. The majority of respondents stated they could implement a protocol. However, barriers of cost, lack of public awareness of naloxone availability, and stigma remain for pharmacies and other naloxone distribution sites.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interests to disclose.

References

    1. Aetna announces new policies to improve access to Narcan, combat overprescribing. Available at: https://news.aetna.com/2017/12/aetna-announces-new-policies-improve-acce... . Accessed July 31, 2019.
    1. Bailey AM, Wermeling DP. Naloxone for opioid overdose prevention: pharmacists’ role in community-based practice settings. Ann Pharmacother 2014; 48:601–606.
    1. Balough MM, Nwankpa S, Unni EJ. Readiness of pharmacists based in utah about pain management and opioid dispensing. Pharmacy 2019; 7:11.
    1. Blue H, Hawthorne AN, Melgaard K, et al. Pharmacist involvement in combating the opioid crisis: a mixed-methods approach revealing conflicting perceptions. J Am Coll Clin Pharm 2020; 3:21–29.
    1. Carpenter DM, Dhamanaskar AK, Gallegos KL, et al. Factors associated with how often community pharmacists offer and dispense naloxone. Res Social Adm Pharm 2018; 15:1415–1418.

Publication types

LinkOut - more resources